1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics, March 2016 (p20)

Biopharmaceutical Analysis & Statistics, March 2016 (p20)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

All regions

571-600 of about 3 100 reports

Purchase Reports From Reputable Market Research Publishers

Global Nucleic Acid Labeling Industry 2016 Market Research Report

Global Nucleic Acid Labeling Industry 2016 Market Research Report

  • $ 2 850
  • Industry report
  • March 2016
  • by 9Dimen Research

2016 Global Nucleic Acid Labeling Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Nucleic Acid Labeling industry, focusing on the main ...

  • Industries : Biopharmaceutical
  • Countries : World, Europe, Asia, North America
Biopharmaceuticals Companies in China

Biopharmaceuticals Companies in China

  • $ 1 800
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

This study focuses on China’s Biopharmaceuticals industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing ...

  • Industries : Biopharmaceutical, Biotechnology, Pharmaceutical
  • Countries : China
Biopharmaceuticals Industry Forecasts - China Focus

Biopharmaceuticals Industry Forecasts - China Focus

  • $ 1 000
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

This study focuses on China’s Biopharmaceuticals industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities ...

  • Industries : Biopharmaceutical
  • Countries : China
Chemotherapy Induced Anemia - Pipeline Review, H1 2016

Chemotherapy Induced Anemia - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • March 2016
  • by Global Markets Direct

Chemotherapy Induced Anemia - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Chemotherapy Induced Anemia - Pipeline Review, H1 2016’, provides an overview of the Chemotherapy Induced ...

  • Industries : Pathology, Therapy, Biopharmaceutical, Oncology, Healthcare, Pharmaceutical
  • Countries : United States
Pfizer Inc. - Product Pipeline Review - 2016

Pfizer Inc. - Product Pipeline Review - 2016

  • $ 1 500
  • Company report
  • March 2016
  • by Global Markets Direct

Pfizer Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Pfizer Inc. - Product Pipeline Review - 2016’, provides an overview of the Pfizer Inc.’s pharmaceutical research and ...

  • Industries : Therapy, Pathology, Cancer
  • Countries : United States
Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2016

Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • March 2016
  • by Global Markets Direct

Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2016’, provides ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Morphotek, Inc. - Product Pipeline Review - 2016

Morphotek, Inc. - Product Pipeline Review - 2016

  • $ 1 500
  • Company report
  • March 2016
  • by Global Markets Direct

Morphotek, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Morphotek, Inc. - Product Pipeline Review - 2016’, provides an overview of the Morphotek, Inc.’s pharmaceutical ...

  • Industries : Cancer, Therapy, Research and Development, Pathology
  • Countries : United States
2016-2020  New Frontiers in the Global Cancer Diagnostics: Business Challenges, Emerging Technologies, Competitive Landscape

2016-2020 New Frontiers in the Global Cancer Diagnostics: Business Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • March 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. VPGMarketResearch.com's new report is a study of the major business opportunities emerging in the global cance ...

  • Industries : Biopharmaceutical
Alzheimer’s Disease - Pipeline Review, H1 2016

Alzheimer’s Disease - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • March 2016
  • by Global Markets Direct

Alzheimer’s Disease - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Alzheimer’s Disease - Pipeline Review, H1 2016’, provides an overview of the Alzheimer’s Disease pipeline landscape. ...

  • Industries : Mental Health, Pathology
  • Countries : United States
F. Hoffmann-La Roche Ltd. - Product Pipeline Review - 2016

F. Hoffmann-La Roche Ltd. - Product Pipeline Review - 2016

  • $ 1 500
  • Company report
  • March 2016
  • by Global Markets Direct

F. Hoffmann-La Roche Ltd. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘F. Hoffmann-La Roche Ltd. - Product Pipeline Review - 2016’, provides an overview of the F. Hoffmann-La ...

  • Industries : Therapy, Pathology, Cancer
  • Countries : United States
2016-2020 Japan Hospital Infectious Disease Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2016-2020 Japan Hospital Infectious Disease Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 3 800
  • Industry report
  • March 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com contains 891 pages, 75 tables, and presents a comprehensive analysis of the Japanese hospital infectious disease testing market, including:  Major issues pertaining ...

  • Industries : Biopharmaceutical
  • Countries : Japan
2016-2020 Italy Hospital Infectious Disease Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2016-2020 Italy Hospital Infectious Disease Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 2 900
  • Industry report
  • March 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com contains 887 pages, 72 tables, and presents a comprehensive analysis of the Italian hospital infectious disease testing market, including:  Major issues pertaining ...

  • Industries : Biopharmaceutical
2016-2020 Germany Hospital Infectious Disease Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2016-2020 Germany Hospital Infectious Disease Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 2 900
  • Industry report
  • March 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com contains 897 pages, 74 tables, and presents a comprehensive analysis of the German hospital infectious disease testing market, including:  Major issues pertaining ...

  • Industries : Biopharmaceutical
  • Countries : Germany
2016-2020 UK Hospital Infectious Disease Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2016-2020 UK Hospital Infectious Disease Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 2 900
  • Industry report
  • March 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com contains 886 pages, 67 tables, and presents a comprehensive analysis of the UK hospital infectious disease testing market, including:  Major issues pertaining ...

  • Industries : Biopharmaceutical
PaxVax, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PaxVax, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary PaxVax, Inc. (PaxVax) is a biotechnology company that develops and commercializes vaccines against infectious diseases. The company’s products include PXVX0200, Vivotif and PXVX0103. It’s PXVX0200, ...

  • Industries : Therapy, Biopharmaceutical
  • Countries : United States
VGX Pharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

VGX Pharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical, Biopharmaceutical, Therapy
  • Countries : United States
Synageva BioPharma Corp. (formerly AviGenics, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Synageva BioPharma Corp. (formerly AviGenics, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
  • Countries : United States
Emergent Biosolutions, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Emergent Biosolutions, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : United States
Morphotek, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Morphotek, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : United States
Profectus BioSciences, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Profectus BioSciences, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States
ImmunoVaccine, Inc. (formerly Rhino Resources, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

ImmunoVaccine, Inc. (formerly Rhino Resources, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : Canada, United States, United Kingdom
PDL BioPharma, Inc. (formerly Protein Design Labs, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

PDL BioPharma, Inc. (formerly Protein Design Labs, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical, Pharmaceutical
  • Countries : United States
Navidea Biopharmaceuticals, Inc. (formerly Neoprobe Corporation) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Navidea Biopharmaceuticals, Inc. (formerly Neoprobe Corporation) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
  • Countries : United States
PATH (Program for Appropriate Technology in Health) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

PATH (Program for Appropriate Technology in Health) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy, Biopharmaceutical, Pharmaceutical
  • Countries : United States
Bavarian Nordic A/S – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Bavarian Nordic A/S – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy, Pharmaceutical, Biopharmaceutical
  • Countries : United States
CTI BioPharma Corp. (formerly Cell Therapeutics, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

CTI BioPharma Corp. (formerly Cell Therapeutics, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy, Biopharmaceutical, Pharmaceutical, Biotechnology
  • Countries : United States
ARCA biopharma, Inc. (formerly Nuvelo, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

ARCA biopharma, Inc. (formerly Nuvelo, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States
Vybion, Inc (formerly Viral Therapeutics, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Vybion, Inc (formerly Viral Therapeutics, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
  • Countries : United States
Keryx Biopharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Keryx Biopharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United Kingdom, Japan, United States
Cytos Biotechnology AG – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cytos Biotechnology AG – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biotechnology, Therapy
  • Countries : United States
About 11 000 reports

Download Unlimited Documents from Trusted Public Sources

Vaccine Industry in Europe

  • June 2016
    90 pages
  • Vaccine  

    Pharmaceutical  

    R-and-D  

  • Europe  

    World  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.